semaglutide tirzepatide equivalent dose vs. Semaglutide: Which is Best for Weight Loss? Switching Semaglutide to Tirzepatide |

Discussion In this mechanistic analysis of the SUMMIT trial, we found that, compared with placebo, treatment with the long-acting glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonist tirzepatide reduced BP and estimates of circulatory volume expansion in patients with obesity-related HFpEF

Oni su nam potvrdili da ovog leka uopte nema ve neko vreme bez naznaka da e ga biti u skorije vreme

This is the most effective dietary defence against GLP-1 weight regain

Lancet Diabetes Endocrinol 6(4): 275-286

Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas